Is targeted therapy for bronchial lung cancer effective? Analysis of targeted treatment methods for lung cancer

Targeted treatment of bronchial lung cancer is primarily aimed at patients with non-small cell lung cancer. Generally speaking, targeted drug treatment can significantly prolong the patient's survival time and improve the patient's quality of life. In addition, targeted drugs have now entered the medical insurance plan and are helpful for the treatment of lung cancer, but the specific effect should be judged based on multiple aspects, which is very important.

Targeted drug therapy for bronchial lung cancer is a method that can control the spread of cancer cells and has a good effect on the patient's tumor treatment. Generally, when using targeted drug therapy, the patient's symptoms can be controlled. However, different patients have different symptoms and different constitutions. What is the specific effect? ​​It is impossible to judge. Let's learn about it below.

Bronchogenic lung cancer is divided into squamous cell carcinoma, adenocarcinoma and small cell lung cancer. Squamous cell carcinoma and adenocarcinoma account for a high proportion of bronchogenic lung cancer, especially adenocarcinoma. Targeted therapy drugs are now the main method to improve the disease. They have little harm to the patient's body and are effective and reliable. It is generally recommended to take the first generation of targeted drugs in the early stage. However, if drug resistance occurs, there is the second generation of afatinib. If it occurs again, there are third generation targeted therapy drugs. Today's targeted therapy drugs are effective and have the effect of improving the quality of daily life of patients, playing an irreplaceable role.

Targeted therapy for lung cancer is undoubtedly the best treatment method with few side effects, but not all lung cancer patients are suitable for targeted therapy. Therefore, lung cancer patients should classify and stage lung cancer with the help of a doctor, and conduct specific gene testing. If a specific target can be found, targeted therapy can be performed. Lung adenocarcinoma is a type of lung cancer and is classified as non-small cell carcinoma. Unlike squamous cell lung cancer, lung adenocarcinoma is more likely to occur in women and non-smokers. It originates from the bronchial mucosal epithelium, and a few originate from the mucous glands of the large bronchi. Understanding the symptoms clearly at this time is also to completely cure the disease in the later stage.

Targeted drug treatment for bronchial lung cancer is the best method to avoid drug resistance. The so-called drug resistance means that when targeted drugs can be used, there is a significant therapeutic effect. Patients need to prevent anxiety during treatment. In addition, during the treatment process, certain lesions will worsen, and this drug will not have much effect on the treatment. Therefore, in the later stage of improving bronchial lung cancer, it is important to receive treatment as soon as possible.